Scholarlink

Objective and design <p>Airway remodelling (AR) is a disabling phenomenon in patients with severe asthma, yet suitable models are lacking. We previously developed a dog allergen-induced murine asthma model characterized by T2<sup>low</sup> Th17-driven neutrophilic airway inflammation and AR. To assess its relevance to human AR associated with T2<sup>low</sup> severe asthma, a condition characterised by poor response to inhaled steroids, we tested the steroid sensitivity of the key features of this model.</p> Material <p>Asthma was induced in C57BL/6&#xa0;J mice by intranasal sensitization, followed by a three-week challenge with dog allergen. <i>Treatment</i>: Daily intraperitoneal 1&#xa0;mg&#xa0;kg<sup>−1</sup> dexamethasone was administrated during the last week of challenge. <i>Methods</i>: We measured airway resistances in response to methacholine, cellular inflammation in bronchoalveolar lavage, lung cytokines, and quantified AR features, in response to dexamethasone.</p> Results <p>Dexamethasone-treated mice showed persistent airway hyperresponsiveness, neutrophilic inflammation, and <i>Il17</i>a overexpression, whereas <i>Il22</i> expression was abrogated. Pathological AR features, including mucus hyperproduction, subepithelial fibrosis and smooth muscle hypertrophy were not eliminated by dexamethasone.</p> Conclusions <p>Our dog allergen-induced murine model of asthma mirrors the steroid-insensitive traits of human severe T2<sup>low</sup> asthma with AR, making it a relevant tool for identifying novel therapeutic targets in this orphan asthma subset.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dog allergen-induced asthma in mice: a relevant model of T2low severe asthma with airway remodelling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月14日

查看全文
  • Victor Margelidon-Cozzolino,
  • Joanne Balsamelli,
  • Julie Carrard,
  • Saliha Ait Yahia,
  • Marie-Hélène Gevaert,
  • Silvia Demoulin-Alexikova,
  • Muriel Pichavant,
  • Anne Tsicopoulos,
  • Cécile Chenivesse,
  • Stéphanie Lejeune,
  • Patricia de Nadai

摘要

Objective and design

Airway remodelling (AR) is a disabling phenomenon in patients with severe asthma, yet suitable models are lacking. We previously developed a dog allergen-induced murine asthma model characterized by T2low Th17-driven neutrophilic airway inflammation and AR. To assess its relevance to human AR associated with T2low severe asthma, a condition characterised by poor response to inhaled steroids, we tested the steroid sensitivity of the key features of this model.

Material

Asthma was induced in C57BL/6 J mice by intranasal sensitization, followed by a three-week challenge with dog allergen. Treatment: Daily intraperitoneal 1 mg kg−1 dexamethasone was administrated during the last week of challenge. Methods: We measured airway resistances in response to methacholine, cellular inflammation in bronchoalveolar lavage, lung cytokines, and quantified AR features, in response to dexamethasone.

Results

Dexamethasone-treated mice showed persistent airway hyperresponsiveness, neutrophilic inflammation, and Il17a overexpression, whereas Il22 expression was abrogated. Pathological AR features, including mucus hyperproduction, subepithelial fibrosis and smooth muscle hypertrophy were not eliminated by dexamethasone.

Conclusions

Our dog allergen-induced murine model of asthma mirrors the steroid-insensitive traits of human severe T2low asthma with AR, making it a relevant tool for identifying novel therapeutic targets in this orphan asthma subset.